As of 3 Nov 2026, EP Biocomposites trades at 10.1× trailing earnings, and the shares are 26% below their 52-week high. Sales and net profit grew 24% and 36% a year over 3 years, with ROCE of 16% and ROE of 13%. Debt is 0.20× equity. It is a small-cap company with a market cap of ₹15 Cr; the shares fell 27% over the past year.
- ₹89.80
- ₹89.80
- ₹85.00
- ₹88.00
- 3K
Health check
- ReturnsWeak
−27.2% over the past year.
- Price tagNo peers
P/E 10.1, with no peers to compare.
- GrowthStrong
Sales +24.1%, profit +36.3% a year over 3 years.
- ProfitabilityAverage
ROCE 16.2%.
- Balance sheetSolid
Debt 0.20× equity, interest covered 6.6×.
- Red flagsNone found
No warning signs in the headline numbers.
Small cap
Market sensitivity
Key metrics
- Market cap
- ₹15 Cr
- Small cap
- P/E
- 10.1
- Price to book
- 1.23
- Book value ₹71.68
- Dividend yield
- 0.00%
- ROE
- 12.9%
- Return on equity
- ROCE
- 16.2%
- Return on capital employed
- Debt to equity
- 0.20
- Debt ₹2.40 Cr
- EPS (TTM)
- ₹8.67
- OPM (TTM)
- 20.4%
- Net margin 10.7%
- Sales growth
- +25.8%
- Latest quarter vs a year ago
- Profit growth
- +64.7%
- Latest quarter vs a year ago
- Price to sales
- 1.08
- EV/EBITDA 6.5
Strengths and risks
Strengths
- Quarterly profit up 64.7% on a year ago.
- Quarterly sales up 25.8% on a year ago.
About EP Biocomposites
EP Biocomposites Limited manufactures and sells fibre reinforced polymer products in India. The company offers bio-digester toilets, sewage and effluent treatment plants, fibre reinforced polymer (FRP) doors, fire doors, and laminated doors; and passive fire protection products, including fire rated cable coating system and electrical/plumbing shaft sealing. It also provides FRP allied products, such as FRP garden benches, security cabins, FRP dust bins,…
- Headquarters
- Panaji
- Employees
- 53
- Sector
- Industrials
- ISIN
- INE0D2I01014
- Website
- epbiocomposites.com
Price range
- Avg volume (3M)
- 717
- 1-year return
- minus 27.2%
- From 52-week high
- minus 26.4%
Peers
We couldn’t find listed peers for this company.
Quarterly results
This company doesn’t report these figures in a format we can read yet.
Profit & loss
- Sales CAGR 3Y
- +24.1%
- Profit CAGR 3Y
- +36.3%
- ROE
- 12.9%
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 7.1 | 11.4 | 12 | 13.6 | |
| – | +60.4% | +5.0% | +13.6% | |
| 6.2 | 9.9 | 10.2 | 11.4 | |
| 1 | 1.6 | 1.8 | 2.2 | |
| 13.7% | 13.6% | 14.9% | 16.5% | |
| 0.1 | 0.1 | 0.1 | 0.1 | |
| 0.2 | 0 | 0.4 | 0.3 | |
| 0.1 | 0.1 | 0.1 | 0.1 | |
| 0.1 | 0 | 0 | −0 | |
| 0.8 | 1.6 | 1.4 | 1.9 | |
| 29.2% | 26.8% | 27.3% | 24.7% | |
| 0.6 | 1.1 | 1 | 1.5 | |
| – | +99.6% | minus 10.3% | +41.5% | |
| 3.94 | 6.84 | 6.13 | – |
Forecast
Balance sheet
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 1.7 | 1.7 | 1.7 | 1.7 | |
| 6.7 | 7.9 | 8.9 | 10.4 | |
| 1.3 | 1.8 | 3 | 2.4 | |
| 2 | 3.7 | 3.1 | 4.3 | |
| 11.7 | 15.1 | 16.6 | 18.7 | |
| 0.2 | 0.4 | 0.3 | 0.8 | |
| – | 0.1 | 0.1 | 0.5 | |
| 2.2 | 1.3 | 1.6 | 2.2 | |
| 9.3 | 13.3 | 14.6 | 15.3 | |
| 11.7 | 15.1 | 16.6 | 18.7 |
Cash flow
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| −0.8 | −1.2 | −0.5 | 2 | |
| 0 | −0.2 | 0 | −0.5 | |
| 2.8 | 0.5 | 0.8 | −0.9 | |
| 2 | −0.9 | 0.3 | 0.5 | |
| −0 | −0.2 | −0 | −0.1 | |
| −0.8 | −1.5 | −0.5 | 1.9 |
Shareholding pattern
This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.
Major shareholders
Filings & events
News
No recent news coverage found.